In the RIP1-TAg2:Vegfr2Y949F/Y949F tumour vasculature, VE-cadherin was preferentially localized at endothelial junctions and the VE-cadherin area was lower than in the WT (Fig. 4g–i). This evidence concerns the gene CDH5 and neoplasm.